medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Number 3

<< Back Next >>

Rev Gastroenterol Mex 2007; 72 (3)

Complications in diagnostic and therapeutic endoscopic cholangiopancreatography. Prospective study

Güitrón-Cantú A, Adalid-Martínez R, Gutiérrez-Bermúdez JA, Nieves-Rentería A, Álvarez-Valdés G

Language: Spanish
References: 41
Page: 227-235
PDF size: 62.66 Kb.


ABSTRACT

Background: Studies of ERCP-related morbidity seldom include a sufficient patient follow-up. The complication rate is variable. Aim: To characterize and to evaluate the frequency of complications in patients after Diagnostic and Therapeutic ERCP. Patients and methods: All patients undergoing ERCP during a 2-year period were included in this prospective study. Complications were assessed at time of ERCP and by personal or telephone contact at 1st, 7, 14 and 30-days after the procedure. Results: A total of 897 ERCPs were included in the analysis, of which 93.9% were therapeutic procedures. 640 were female with age of 49.68 (± 18.59) and 257 male with age 58.80 (± 16.67). The 30-day complications rate was 3.19%; the procedure-related mortality rate was 0.11%. Mild hemorrhage occurred in 1.48% and moderate hemorrhage in 0.11%. Post-ERCP pancreatitis occurred in 0.79% and duodenal perforation in 0.45%. The 30-day procedure-no related mortality was 1.14%. Conclusion: This prospective study confirms the complications rate of ERCP including therapeutic procedures is low in our experience.


REFERENCES

  1. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, et al. Complications of Endoscopic Biliary Sphincterotomy. N Engl J Med 1996; 335: 909-18.

  2. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, et al. Complications of Diagnostic and Therapeutic ERCP: A Prospective Multicenter Study. Am J Gastroenterol 2001; 96: 417-23.

  3. Christensen M, Matzen P, Schulze S, Rosenberg J. Complications of ERCP: a prospective study. Gastrointest Endosc 2004; 60: 721-31.

  4. Freeman ML. Complications of Endoscopic Biliary Sphincterotomy: A Review. Endoscopy 1997; 29: 288-97.

  5. Rabenstein T, Schneider HT, Nicklas M, Katalinic A, Hahn EG, et al. Analysis of the Risk Factors Associated with Endoscopic Sphincterotomy Techniques: Preliminary Results of a Prospective Study, with Emphasis on the Redioced Risk of Acute Pancreatitis with Low-Dose Anticoagulation Treatment. Endoscopy 2000; 32(1): 10-9.

  6. Güitrón A, Adalid R, Gutiérrez-Bermúdez A. Esfinterotomía Endoscópica (EE) como procedimiento ambulatorio: ¿es seguro? Rev Gastroenterol Mex 2003; 68: 178-84.

  7. Güitrón A, Adalid R. Seguridad y eficacia en la esfinterotomía guiada y con técnica de precorte. Experiencia en 5 años. Rev Gastroenterol Mex 1996; 61: 342-7.

  8. Güitrón A, Adalid R, Barinagarrementería R, Gutiérrez JA. Esfinterotomía de precorte: Eficacia y complicaciones. Rev Gastroenterol Mex 1998; 63(3): 148-52.

  9. Cotton PB, Lehman G, Venees J, et al. Endoscopic Sphincterotomy complications and their management; an attempt to consensus. Gastrointest Endosc 1991; 37: 383-93.

  10. Neoptolemos JP, Shaw DE, Carr-Locke DL. A multivariate analysis of preoperative risk factors in patients with common bile duct stones. Ann Surg 1989; 9: 157-61

  11. Sherman S, Ruffolo TA, Hawes RH, et al. Complications of endoscopic sphincterotomy: A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non dilated bile duct. Gastroenterology 1991; 101: 1068-75.

  12. Boender J, Nix GA, De Ridder HA. Endoscopic papillotomy for common bile duct stones influencing the complications rate. Endoscopy 1994; 26: 209-16.

  13. Chen YK, Foliente RL, Santoto MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with non-dilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89: 327-33.

  14. Wojtum S, Gil J, Gietka W, Gil M. Endoscopic Sphincterotomy for Choledocholithiasis: A Prospective Single-Center Study on the Short-Term and Long-Term Treatment Results in 438 Patients. Endoscopy 1997; 29: 258-65.

  15. American Society for Gastrointestinal Endoscopy. Complications of ERCP. Gastrointest Endosc 2003; 57: 633-8.

  16. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Eng J Med 1996; 335: 919-23.

  17. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study: Gastrointest Endosc 2001; 54: 425-34.

  18. Rabenstein T, Scheider HT, Hahn EG, et al. 25 years of endoscopic sphincterotomy in Erlanger: assessment of experience in the treatment of 3498 patients. Endoscopy 1998; 30(Suppl. 2): A194-A201.

  19. Loperfido S, Agelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48: 1-10.

  20. Ponchon T. Diagnostic Endoscopic Retrograde Cholangiopancreatography. Endoscopy 2000; 32(3): 2: 200-8.

  21. Elta GH. ERCP/Sphincterotomy. Minimizing Endoscopic Complications. ASGE Annual Postgraduate Course 2005; 167-70.

  22. Park do H, Kim MH, Lee SK, et al. Endoscopic sphincterotomy versus endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc 2004; 60: 180-5.

  23. Tsujino T, Isayama H, Kamatsu Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic balloon dilation. Am J Gastroenterol 2005; 100: 38-42.

  24. Lella F, Bagnolo C, Colombo E, et al. A simple way of avoiding post- ERCP pancreatitis. Gastrointest Endosc 2004; 59: 830-4.

  25. Manes G, Ardizzone S, Lombarda G, et al. Efficacy of post procedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study. Gastrointest Endosc 2007; 65: 982-7.

  26. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004; 59: 845-64.

  27. Testoni PA, Mariani A, Masci E, et al. Frequency of post-ERCP pancreatitis in a single tertiary referral center without and with routine prophylaxis with gabexate: a 6-year survey and cost-effective analysis. Dig Liver Dis 2006; 38: 588-95.

  28. Budzynska A, Marek T, Nowak A, et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001; 33: 766-72.

  29. Andriulli A, Solmi L, Loperfido S, et al. Prophylaxis or ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2004; 2: 713-8.

  30. Montaño LA, García CJ, González OA, et al. Prevención de hiperamilasemia y pancreatitis posterior a la colangiopancreatografía retrógrada endoscópica con la administración rectal de indometacina. Rev Gastroenterol Mex 2006; 71: 262-8.

  31. Das A, Singh P, Sivak MV, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007; 65: 960-8.

  32. Fogel EL, Eversman D, Jamidar P, et al. Sphincter of Oddi dysfunction; pancreatobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 2002; 34: 280-5.

  33. Vandervoort J, Soetikno RM, Tham TC, et al. Risk factors for complications alter performance of ERCP. Gastrointest Endosc 2002; 56: 652-6.

  34. Silverman WB. ERCP and prophylactic pancreatic stents: raising the bar, reducing the pain. Gastrointest Endosc 2007; 65: 969-70.

  35. Freeman ML, Overby C, Qi D. Pancreatic stents insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004; 59: 8-14.

  36. Rashdan A, Fogel EL, McHenry L, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2004; 2: 322-9.

  37. Güitrón A, Adalid R, Gutiérrez-Bermúdez JA. Manejo conservador de la perforación duodenal secundaria a esfinterotomía endoscópica (EE) de la papila de Vater. Rev Gastroenterol Mex 2003; 68: 6-10.

  38. Cotton PB. Precut papillotomy – a risky technique for expert only. Gastrointest Endosc 1989; 35: 578-78.

  39. Binmoeller KF, Seifert H, Gerke H, et al. Papillary roof incision using the Erglangen-type pre-cut papillotome to achieve bile duct cannulation. Gastrointest Endosc 1996; 44: 689-95.

  40. Leung JWC, Banez VP, Chung SCS. Precut (needle knife) papillotomy for impacted common bile duct stone at the ampulla. Am J Gastroenterol 1990; 85: 991-3.

  41. Shakoor T, Geenen JE. Pre-cut papillotomy. Gastrointest Endosc 1992; 38: 623-7.




2020     |     www.medigraphic.com